Epinephrine Improves Outcomes in Out-Of-Hospital Cardiac Arrests.

Area of Science:

• Emergency Medicine
• Cardiology
• Critical Care Medicine

Background:

• Epinephrine is a standard medication for cardiac arrest (CA).
• Its role in improving patient survival and neurologic outcomes is debated.
• Current guidelines recommend epinephrine during CA resuscitation.

Purpose of the Study:

• To evaluate the association between epinephrine use and outcomes in cardiac arrest.
• To determine if higher doses of epinephrine improve survival or neurologic function.
• To assess the impact of cumulative epinephrine dose on neurologic outcomes post-ROSC.

Main Methods:

• Retrospective analysis of cardiac arrest patient data.
• Comparison of outcomes based on epinephrine administration (yes/no).
• Analysis of outcomes related to standard-dose vs. high-dose epinephrine and cumulative dose thresholds.

Main Results:

• Epinephrine use was associated with increased return of spontaneous circulation (ROSC).
• No significant improvement in survival with good neurologic outcomes was observed despite increased ROSC.
• High-dose epinephrine and cumulative doses >3 mg did not improve hospital discharge, long-term survival, or neurologic outcomes, and were linked to poor neurologic outcomes.

Conclusions:

• While epinephrine facilitates ROSC in cardiac arrest, it does not improve meaningful survival outcomes.
• High-dose and cumulative epinephrine administration in CA are not associated with better patient survival or neurologic recovery.
• Increased cumulative epinephrine doses correlate with worse neurologic outcomes after ROSC, suggesting a potential harm threshold.